Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Erick Lucera

CFO at Dyne Therapeutics, Inc. (DYN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $229K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 17SEC DYNDyne Therapeutics, Inc. Sell Plan 1,797119,766 held (−1%) $26.28 $47K -45.8%
Jun 26SEC DYNDyne Therapeutics, Inc. Sell 2,362121,563 held (−2%) $20.37 $48K -30.0%
May 14SEC DYNDyne Therapeutics, Inc. Sell Plan 1,448123,925 held (−1%) $18.36 $27K -22.4%
Apr 3SEC DYNDyne Therapeutics, Inc. Sell Plan 5,727125,373 held (−4%) $18.64 $107K -23.6%
  • Sell

    CFO Erick Lucera sold $47K of DYN at $26.28 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Erick Lucera sold $27K of DYN at $18.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Erick Lucera sold $107K of DYN at $18.64 — pre-scheduled 10b5-1 plan sale.